Chatbots Seem More Empathetic Than Docs in Cancer DiscussionsMay 16, 2024Patient & Survivor CareDLBCLMixed TopicsPediatricsBusiness of MedicineALLAML
FDA Broadens Breyanzi’s Follicular Lymphoma IndicationMay 16, 2024Non-Hodgkin LymphomaCellular TherapyIndolent Lymphoma
Survey Spotlights Identification of Dermatologic Adverse Events From Cancer TherapiesMay 13, 2024Mixed TopicsDLBCLPatient & Survivor CareCLLCMLAggressive LymphomasALL
New mRNA Vaccines in Development for Cancer and InfectionsMay 10, 2024Patient & Survivor CareCOVID-19 UpdatesDLBCLMixed TopicsPediatricsAggressive LymphomasALL
Can a Risk Score Predict Kidney Injury After Cisplatin?May 10, 2024Patient & Survivor CareMixed TopicsALLAMLAggressive LymphomasB Cell LymphomaCLL
Do Patients Benefit from Cancer Trial Participation?May 8, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Do Health-Related Social Needs Raise Mortality Risk in Cancer Survivors?May 7, 2024Patient & Survivor CareMixed TopicsDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Terminal Cancer: What Matters to Patients and CaregiversMay 7, 2024Patient & Survivor CareDLBCLMixed TopicsAggressive LymphomasALLAMLB Cell Lymphoma
The Long, Controversial Search for a ‘Cancer Microbiome’May 6, 2024Patient & Survivor CarePediatricsDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
